Outpatient Therapeutics

January 31, 2023
Outpatient Therapeutics DOH Issues Revised Guidance on COVID-19 Treatment Recommendations: Members encouraged to share information with their medical directors and physicians.; Read More; Tags: COVID-19

January 26, 2023
Outpatient Therapeutics DOH Advisory: Updates on COVID-19 Treatment Recommendations: Read More; Tags: COVID-19

November 30, 2022
Outpatient Therapeutics DOH Advisory: Updates on COVID-19 Treatment Recommendations: Read More; Tags: COVID-19

May 31, 2022
Outpatient Therapeutics DOH Issues Health Advisory Regarding Paxlovid Use: Advisory relates to use of Paxlovid and potential for rebound COVID-19 after treatment.; Read More; Tags: COVID-19

May 24, 2022
Outpatient Therapeutics DOH Advisory: COVID-19 Rebound After Paxlovid Treatment: Read More; Tags: COVID-19

April 25, 2022
Outpatient Therapeutics Access to COVID-19 Therapeutics: Reminders for Nursing Homes: Nursing homes that operate their own pharmacy must enroll in a specialized system to request monoclonal antibody therapies and may request oral antivirals by sending a request to covid19therapeutics@health.ny.gov or through the Health Partner Order Portal. Nursing homes that do not operate their own pharmacy may access therapeutics through their LTC pharmacy.; Read More

April 19, 2022
Outpatient Therapeutics DOH Advisory: COVID-19 Oral Antiviral Treatment Available: Read More; Tags: COVID-19

March 29, 2022
Outpatient Therapeutics DOH Issues Advisory on Pause in Distribution of Sotrovimab: Currently authorized alternative treatments, including Paxlovid, molnupiravir, and bebtelovimab, available for distribution.; Read More; Tags: COVID-19

March 25, 2022
Outpatient Therapeutics DOH Advisory: Pause in Distribution of Sotrovimab: Read More; Tags: COVID-19

March 4, 2022
Outpatient Therapeutics DOH Advisory: Test Soon and Treat Early to Improve Outcomes from COVID-19: Read More; Tags: COVID-19